menu search

Syfovre® (pegcetacoplan injection) continued to demonstrate increasing treatment effects over 3 years in patients with geographic atrophy (ga)

SYFOVRE reduced nonsubfoveal GA lesion growth by over 40% (monthly) in Year 3 compared to projected sham in the GALE extension study Well-demonstrated...

November 4, 2023, 5:37 pm

Sensei biotherapeutics reports favorable clinical data for sns-101 at 2023 sitc annual meeting

– Clinical dose escalation data for SNS-101 monotherapy show well tolerated safety profile, potentially best-in-class pharmacokinetics, and encourag...

November 3, 2023, 8:05 pm

Prime medicine reports third quarter 2023 financial results and provides business updates

presented new preclinical research across multiple programs, including proof-of-concept data from i...

November 3, 2023, 8:01 pm

Kineta reports third quarter 2023 financial results and provides corporate update

Announced positive KVA12123 monotherapy safety data from its ongoing phase 1/2 VISTA-101 clinical trial Enrolled the first patient of KVA12123 in comb...

November 3, 2023, 8:01 pm

New preliminary clinical data on potential of opus aav-based gene therapy for rare inherited retinal disease to be presented at the american academy of ophthalmology annual conference 2023

Data to be presented as part of gene augmentation therapy presentation RALEIGH, N.C., Nov. 03, 2023 (GL...

November 3, 2023, 7:43 pm

Travere therapeutics announces late-breaking data from phase 3 studies of sparsentan in igan and fsgs published in the lancet and the nejm respectively and presented at the american society of nephrol

Two-year results from both PROTECT and DUPLEX pivotal Phase 3 studies demonstrate treatment with sparsentan has the potential to preserve kidney funct...

November 3, 2023, 2:46 pm

Parsons’ carey smith named government contracting executive of the year

CHANTILLY, Va., Nov. 03, 2023 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE:PSN) Chair, President, and Chief Executive Officer, Carey Smith, was reco...

November 3, 2023, 2:45 pm

Morphic announces corporate highlights and financial results for the third quarter 2023

-presented positive EMERALD-1 Phase 2a data for MORF-057 in patients with moderate to severe ulcerative...

November 3, 2023, 11:00 am

'helpful' ai could carry out illegal insider trades and cover its tracks, research finds

Artificial intelligence (AI) systems might have the potential to engage in unauthorized financial transactions and subsequently deny such actions, acc...

November 3, 2023, 4:08 am

Dbv technologies to present new data at acaai 2023

Montrouge, France, November 2, 2023 DBV Technologies to Present New Data at ACAAI 2023 New data to include late-breaking abstract detailing interim 12...

November 2, 2023, 4:30 pm

In8bio to present new positive data from phase 1 trial of inb-100 at 2023 american society of hematology (ash) annual meeting

New data on the completed dose-escalation of this Phase 1 trial highlights promising efficacy of INB-100 in patients with hematologic malignancies; up...

November 2, 2023, 1:17 pm

Springworks therapeutics reports third quarter 2023 financial results and recent business highlights

– PDUFA target action date for nirogacestat NDA in adults with desmoid tumors remains set for November 27, 2023 – – On track to report topline d...

November 2, 2023, 10:30 am

Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato

BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today announced that new data from an additional 52-w...

November 2, 2023, 9:09 am

Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato

BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today announced that new data from an additional 52-w...

November 2, 2023, 9:09 am

Mixed results in october 2023 forex trading across global markets

Spot currency trading in October 2023 presented mixed data for another consecutive month regarding inst...

November 1, 2023, 7:59 am

Xilio to host virtual investor conference call and webcast on monday, november 6, 2023 to review progress across pipeline, including phase 1/2 clinical data for xtx202, a tumor-activated, engineered,

WALTHAM, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and devel...

October 31, 2023, 9:15 am

Sam bankman-fried faces cross-examination: what led to ftx's collapse?

During his ongoing criminal trial, Sam Bankman-Fried (SBF) faced some tough questions from New York prosecutors today (Monday). The once prominent fig...

October 30, 2023, 8:42 pm

Winnebago industries showcases marine innovation from barletta, chris-craft at the fort lauderdale boat show

EDEN PRAIRIE, Minn., Oct. 30, 2023 (GLOBE NEWSWIRE) — Winnebago Industries, Inc. (NYSE: WGO), a leading outdoor lifestyle product manufacturer, rece...

October 30, 2023, 5:10 pm

Australian retails rose 0.9% mom, strong sep in subdued 2023

Australia’s retail sales turnover registered a 0.9% mom growth in September to AUD 35.87B. This robust performance dwarfed the modest analyst expect...

October 30, 2023, 2:58 am

Kongsberg gruppen asa (nskff) q3 2023 earnings call transcript

Kongsberg Gruppen ASA (OTCPK:NSKFF) Q3 2023 Earnings Conference Call October 27, 2023 2:15 AM ET Company Participants Jan Erik - VP, IR Geir Haoy - Pr...

October 30, 2023, 12:12 am


Search within

Pages Search Results: